Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
May, Kathleen
NCT05722522: Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy	Active, not recruiting	3	34	Europe, Canada, US, RoW	Secukinumab, AIN457, Placebo	Novartis Pharmaceuticals	Rotator Cuff Tendinopathy	10/24	12/24
NCT06000410: A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee	Recruiting	3	474	US	Amniotic Suspension Allograft, Placebo	Organogenesis	Knee Osteoarthritis	09/25	03/26
Corona, Patricia
NCT04886258 / 2020-006104-17: Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis	Completed	2	115	Europe, US, RoW	DFV890, Placebo	Novartis Pharmaceuticals, Novartis Pharma AG	Symptomatic Knee Osteoarthritis	12/24	12/24
Ramirez, Eva
NCT05722522: Study of Efficacy and Safety of Secukinumab in Participants With Moderate-severe Rotator Cuff Tendinopathy	Active, not recruiting	3	34	Europe, Canada, US, RoW	Secukinumab, AIN457, Placebo	Novartis Pharmaceuticals	Rotator Cuff Tendinopathy	10/24	12/24
Maddox, Delbert
NCT04886258 / 2020-006104-17: Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis	Completed	2	115	Europe, US, RoW	DFV890, Placebo	Novartis Pharmaceuticals, Novartis Pharma AG	Symptomatic Knee Osteoarthritis	12/24	12/24